Advertisement
Person › Details
Markus Hosang (BioMedPartners AG)
Hosang, Markus (BioMedPartners 201108 General Partner)
Organisation | BioMedPartners AG | |
Group | BioMedPartners (Group) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Record changed: 2022-11-18 |
Advertisement
More documents for Markus Hosang
- [1] ImmunOs Therapeutics AG. (12/10/19). "Press Release: ImmunOs Therapeutics AG Raises CHF 15M in Series A Financing, Co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer into Human Trials". Schlieren....
- [2] BioMedPartners AG. (3/1/18). "Press Release: BioMedPartners Close Their New Healthcare Venture Fund BioMedInvest III at CHF 100 Million". Basel....
- [3] BioMedPartners AG. (2/16/17). "Press Release: BioMedPartners Raise CHF 75 Million in First Closing of Their New Healthcare Venture Fund". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top